Stay updated on Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.

Latest updates to the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page
- Check5 days agoChange DetectedFooter updates add Revision: v3.3.3 and remove HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe site revision label in the footer updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved the general operating-status notice about government funding. This does not affect the study details, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check55 days agoChange DetectedTwo screenshots show the same Study Details page with identical content and layout; no changes were detected.SummaryDifference0.4%

- Check83 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference4%

- Check90 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.